Jenny Rooke, Ph.D.
Jenny is the Managing Director at 5 Prime Ventures, where she invests in early stage life sciences companies specializing in research tools, diagnostics, and synthetic biology. Jenny’s investing experience includes roles at F-Prime Capital, where she served as a Kauffman Fellow, Anterra Capital, and with the Bill & Melinda Gates Foundation. Prior to investing, she held multiple executive positions at U.S. Genomics, a life venture-backed science tools start-up focused on advancing single molecule detection technologies. While there, Jenny was responsible for the development and launch of the company’s first product line, assays for microRNA detection. She also led internal science and marketing teams in analyses of potential applications/markets for the company’s technologies and co-invented a novel genetic testing method that was licensed to Quest Diagnostics, generating a revenue stream. Dr. Rooke holds a PhD in genetics from Yale University and a BS in Physics from Georgia Tech.